Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Trop Geogr Med ; 44(1-2): 1-8, 1992 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-1496699

RESUMO

Children with Plasmodium falciparum infections in Western Province, Kenya, were studied in 1987 for their parasitological, clinical and haematological response to chloroquine, to amodiaquine and to pyrimethamine-sulfadoxine plus quinine. Ninety-eight children under 5 years of age were treated in 1 of 2 hospitals. Of the 56 patients treated with chloroquine base 25 mg/kg, 91% had resistant infections, with 36% having no significant decrease in parasitaemia (RIII resistance); however, 69% responded clinically within a week. Of the 27 patients treated with amodiaquine base 25 mg/kg, 67% had resistant infections, with 7% RIII resistant; 81% responded clinically. The parasites cleared in all 15 children given pyrimethamine-sulfadoxine plus 3 days of quinine. Only when parasites cleared did patients have improved haemoglobins and haematocrits. This study shows that parasitaemia in children hospitalized in western Kenya responds poorly to 4-aminoquinolines, although the patients improve clinically, at least during the first 7 days. Young children may need to clear parasites to avoid the risk of severe anemia and the need for blood transfusions.


Assuntos
Antimaláricos/uso terapêutico , Malária Falciparum/tratamento farmacológico , Amodiaquina/administração & dosagem , Amodiaquina/uso terapêutico , Antimaláricos/administração & dosagem , Cloroquina/administração & dosagem , Cloroquina/uso terapêutico , Combinação de Medicamentos , Resistência a Medicamentos , Quimioterapia Combinada , Contagem de Eritrócitos , Feminino , Hematócrito , Hemoglobinas/análise , Hospitais , Humanos , Lactente , Quênia/epidemiologia , Malária Falciparum/sangue , Malária Falciparum/epidemiologia , Masculino , Pirimetamina/administração & dosagem , Pirimetamina/uso terapêutico , Quinina/administração & dosagem , Quinina/uso terapêutico , Reticulócitos/química , Estudos Soroepidemiológicos , Sulfadoxina/administração & dosagem , Sulfadoxina/uso terapêutico
3.
Brain Res ; 507(1): 92-100, 1990 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-2105824

RESUMO

Bilateral 6-hydroxydopamine (6-OHDA) lesions in the nucleus accumbens of rats induced motor hypoactivity 7 days after the lesion. Spontaneous functional recovery of this impaired behavior occurred in 3-4 weeks. Behavioral and biochemical studies suggest that the hypoactivity is due to damage of the dopamine systems in the nucleus accumbens. The 6-OHDA lesions induced a decrease in the nucleus accumbens levels of dopamine and its metabolites of about 30% both 7 and 20 days after the lesion. The in vitro uptake of [3H]dopamine in nucleus accumbens tissue of the 6-OHDA-lesioned rats was decreased to the same extent at 7, 14 and 28 days after the lesion. Scatchard analysis of [3H]haloperidol binding studies in nucleus accumbens tissue revealed a shift from one type of binding site in tissue of sham-lesioned rats to two types of binding sites in tissue of 6-OHDA-lesioned rats 29 days after the lesion. This shift was not present in nucleus accumbens tissue 8 days after a 6-OHDA lesion. The spontaneously recovered rats showed an enhanced behavioral response upon administration of the dopamine agonist apomorphine. The present data suggest that the spontaneous functional recovery of impaired motor activity is caused by the development of supersensitivity of the dopamine receptor systems in the nucleus accumbens. This supersensitivity may be the result of increased affinity of one type of binding site or an increased number of functional binding sites.


Assuntos
Dopamina/fisiologia , Atividade Motora/fisiologia , Núcleo Accumbens/fisiologia , Receptores Dopaminérgicos/fisiologia , Núcleos Septais/fisiologia , Animais , Dopamina/metabolismo , Haloperidol/metabolismo , Hidroxidopaminas , Masculino , Núcleo Accumbens/metabolismo , Oxidopamina , Ratos , Ratos Endogâmicos , Receptores Dopaminérgicos/metabolismo
4.
Brain Res ; 507(1): 101-8, 1990 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-2154293

RESUMO

Functional recovery from motor hypoactivity of rats with 6-OHDA lesions in the nucleus accumbens is accelerated by intra-accumbal or subcutaneous treatment with the ACTH-(4-9) analog ORG 2766. The spontaneous recovery period of 3 weeks is shortened to 7 days by daily treatment with this peptide during the first 6 days after the lesion. The 6-OHDA lesion induced a decrease of about 30-40% in the levels of dopamine, HVA and DOPAC as well as in the uptake of [3H]dopamine in nucleus accumbens tissue in vitro. Treatment with ORG 2766 during the first 6 days following the lesion did not affect the lesion-induced changes in these biochemical parameters. Binding studies with [3H]haloperidol in nucleus accumbens tissue of placebo or ORG 2766-treated sham-lesioned rats revealed a linear Scatchard plot 7 days after the sham lesion. In tissue of placebo-treated 6-OHDA lesioned animals a similar linear Scatchard plot was found but in tissue of ORG 2766-treated 6-OHDA-lesioned rats the Scatchard plot was curvilinear in shape indicating two types of binding sites. In the 6-OHDA-lesioned rats treated with ORG 2766 the behavioral response upon apomorphine challenge was enhanced suggesting the existence of functional supersensitivity of the DA system. Similar changes in Scatchard plots and apomorphine-induced behavioral changes have been previously reported after spontaneous recovery. The present study indicates that ORG 2766 accelerates the process of functional recovery from impaired motor behavior of rats with 6-OHDA lesions in the nucleus accumbens, which may be due to development of denervation supersensitivity.


Assuntos
Hormônio Adrenocorticotrópico/análogos & derivados , Hormônio Adrenocorticotrópico/farmacologia , Dopamina/fisiologia , Atividade Motora/efeitos dos fármacos , Núcleo Accumbens/fisiologia , Fragmentos de Peptídeos/farmacologia , Núcleos Septais/fisiologia , Animais , Apomorfina/farmacologia , Dopamina/metabolismo , Haloperidol/metabolismo , Masculino , Núcleo Accumbens/efeitos dos fármacos , Núcleo Accumbens/metabolismo , Ratos , Ratos Endogâmicos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...